Table 2 Crude number of adverse events during follow-up
Follow-up outcomes | Total (n = 1113) | Diabetes (n = 266) | Non- diabetes (n = 847) |
|---|---|---|---|
MACE, n (%) | 97 (8.7) | 33 (12.4) | 64 (7.6) |
Cardiovascular death, n (%) | 20 (1.8) | 6 (2.3) | 14 (1.7) |
MI, n (%) | 26 (2.3) | 10 (3.8) | 16 (1.9) |
Hospitalization for unstable angina, n (%) | 56 (5.0) | 23 (8.6) | 33 (3.9) |
Hospitalization for heart failure, n (%) | 10 (0.9) | 3 (1.1) | 7 (0.8) |
All-cause mortality, n (%) | 43 (3.9) | 15 (5.6) | 28 (3.3) |
Composite of all events, n (%) | 119 (10.7) | 41 (15.5) | 78 (9.2) |